Contact

SARS-CoV-2 mRNA Vaccine BNT162b2 Elicited a Robust Humoral and Cellular Response Against SARSCoV-2 Variants

Daniele Lilleri et.al., Research Square (2021) - PMID: n.a.

Product(s) used in this publication: PepMix™ Peptide Pools

Abstract
 

n.a.

Stay in touch and be the first to receive the latest news!